Systematic review of aortic valve preservation and repair. by Saczkowski, Richard et al.
Available at:
http://hdl.handle.net/2078.1/159319
[Downloaded 2019/04/19 at 06:05:43 ]
"Systematic review of aortic valve preservation and repair."
Saczkowski, Richard ; Malas, Tarek ; de Kerchove,
Laurent ; El Khoury, Gebrine ; Boodhwani, Munir
Abstract
Aortic valve repair has emerged as a feasible alternative to replacement in the
surgical treatment of selected patients with aortic valve (AV) pathology. In order
to provide a synopsis of the current literature, we preformed a systematic review
with a focus on valve-related events following AV repair.
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Introduction
Aortic valve preservation and repair is emerging as a feasible
alternative to aortic valve replacement in the treatment of 
aortic root pathology with or without aortic insufficiency 
(Figure 1). Preservation of the native aortic valve leaflets 
has gained popularity in cardiac centers worldwide due 
to the success of repair techniques and the potential of 
avoiding the long-term complications of prosthetic valves. 
However, unlike the mitral valve, which is associated with 
a relatively high proportion of repair, aortic valve repair is 
only performed in less than 2% of all aortic valve surgery 
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(1). This difference is largely due to the fact that the most 
commonly seen pathology of the aortic valve is calcific 
aortic stenosis, which is not amenable to repair. In addition, 
there is a much longer and more established experience 
with successful mitral valve repair techniques (2). 
Ideally, a prosthetic valve should sustain excellent 
hemodynamics at rest and exercise, have minimal 
transaortic pressure gradients, should be durable in the 
long-term, resist thrombus formation without the need for 
anticoagulation, and be simple to implant. Unfortunately, 
the ideal prosthetic valve does not yet exist. Instead, native 
valve disease is typically replaced by “prosthetic valve 
disease” (3). Current prosthetic devices are associated with 
complications including, but not limited to, valve thrombosis 
and thromboembolic events, bleeding events associated 
with anticoagulation use, prosthetic valve endocarditis, 
and structural valve deterioration (4). In effect, successful 
aortic valve repair has become an attractive alternative in 
circumventing these potential complications by preservation 
of the native aortic valve apparatus. The long-term outcome 
following aortic valve repair, however, remains uncertain.
In an effort to summarize valve repair data from centers 
worldwide, Savage and Carr have completed an extensive 
systematic review of 11 major studies from 1990-2002 
addressing valve repair for aortic insufficiency in adults (2). 
Although many studies reported 5- or 10-year outcomes 
after valve repair, data for long-term outcomes was scarce. 
Furthermore, a large proportion of patients in these studies 
undergoing valve repair had rheumatic valve disease, which 
has been associated with poor long-term outcome. Although 
the systematic review presented a large proportion of aortic 
valve repairs in the decade from 1990-2002, valve repair 
techniques have since evolved. Therefore, we performed 
a systematic review of studies published from 2002-2011, 
aiming to assess outcomes and complications associated 
with reconstructive valve surgery.
Methods
Search strategy
Structured keyword searches of PubMed [1966-2012] and 
Embase [1980-2012] were performed on January 25, 2012 
using (aortic valve repair) OR (aortic valve reconstruction) 
OR (aortic valve preservation) OR (valve-sparing root 
replacement) with human, adult and English language 
limitations. Articles were deemed eligible for inclusion if 
they were observational studies published after 2002, and 
reported morbidity or mortality for aortic valve repair 
or preservation. Articles were excluded if they were case 
reports, if they had a substantial proportion of acute aortic 
dissections (>25%), or when only a specific sub-population 
of AV repair was evaluated (e.g., bicuspid AV, rheumatic, 
etc.). In order to obtain meaningful data on long-term 
outcomes, studies were also excluded when there was less 
than 100 patient-years follow-up. Two reviewers (R.S. 
and T.M.) screened titles and abstracts to identify articles 
for full-text review. In the case of multiple publications 
of overlapping patient populations from the same center, 
the study with the largest number of patient-years or most 
recent year of publication was selected. Reference lists 
of included articles were screened to aid in identification 
of relevant studies. No authors required contact for 
clarification of published data.
Data extraction and analysis
Microsoft  Excel  for  Windows was  used for  data 
extraction and statistical analysis. One reviewer (R.S.) 
transcribed data into a standardized collection form. 
A second reviewer (M.B.)  verif ied extracted data 
and discrepancies were rectified through consensus. 
Patient-years (pt-yrs) were calculated for each study 
by multiplying the number of patients with the mean 
follow-up time. Outcome events were catalogued 
according to the definitions described by the Liaison 
Committee for Standardized Definitions of Prosthetic 
Figure 1 Aortic valve-sparing surgery using the re-implantation 
technique
5Annals of cardiothoracic surgery, Vol 2, No 1 January 2013
© AME Publishing Company. All rights reserved. Ann Cardiothorac Surg 2013;2(1):3-9www.annalscts.com
Heart Valves (5).  Studies not reporting a specific 
outcome measure were excluded from analysis of that 
outcome. Early mortality was presented as a percent, 
while late mortality and valve-related outcomes were 
linearized [(number of events/number of patient-years) × 
100] for each study. A composite outcome was used for 
late thromboembolic and neurological events. Summary 
effects measures for early and late mortality were 
obtained by logarithmically pooling data with an inverse-
variance weighted fixed effects model. The summary 
effects measures were presented with a 95% confidence 
interval (95% CI). When early or late mortality was 
reported as zero, the value was adjusted to an event rate 
of 0.5 to permit computation in the fixed effects model. 
If early or late mortality was not reported in an article, 
it was excluded from the pooled analysis. Heterogeneity 
of the summary effects measures were assessed with the 
I2 test and considered present when I2>50%. Continuous 
data were presented as a median and range.
Results
Identification of studies
The keyword search results of PubMed and Embase produced 
5,325 potentially relevant articles (Figure 2). After removal 
of duplicate studies present in both search engines, 3,507 
unique articles remained. Further screening for relevance 
by title and abstract removed an additional 3,299 papers. 
The resulting 208 studies were restricted based on the year of 
publication (January 2002 - January 2011), which led to the 
identification of 111 studies. Full-text review of these articles 
were performed by two reviewers (R.S. and M.B.) and articles 
were further excluded due to the following reasons: large 
proportion of acute aortic dissections, studies including only 
subgroups of AV disease, duplicate cohorts, patient-years < 
100, paediatric population, lack of relevant outcomes, as 
summarized in Figure 2. After the selection process, 16 unique 
studies were identified for inclusion. A reference list review of 
these articles was undertaken and one additional article was 
Figure 2 Study selection flow chart
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identified for inclusion. In summary, after screening 3,507 
unique articles, 17 studies were included for quantitative 
assessment in the present systematic review (4,6-21).
Study characteristics
There were no randomized trials comparing aortic valve 
repair to replacement. The majority of studies reported single 
institutional data (6,8,10-21). However, two studies reported 
outcomes from multi-center experiences (7,9). Pooling the 
populations from the studies produced a total of 2,891 patients 
that underwent AV repair (4,6-21) (Table 1). The median 
follow-up time was 3.9 yrs (1.4-15 yrs), which produced a 
median follow-up period of 387 pt-yrs (116-3,072 pt-yrs). 
The majority of the patients who underwent AV repair were 
male (median: 76.4%, range, 64.4-82.6%), with a median 
age of 53.5 yrs (range, 32.9-61.0 yrs). Tricuspid (4,6,8,13,17) 
and bicuspid (4,6-10,13,16,19-21) aortic valve pathology 
were present in 65% (range, 21-100%) and 13.5% (range, 
5-100%) of the population, respectively. Preoperative aortic 
insufficiency (AI) greater than 2+ was present in a median 
of 52% (range, 0-93%) of patients. Cusp repair techniques 
were applied in a median of 46% (range, 5-100%) of 
patients (4,6,7,9-13,15-21). 
Aortic root reconstruction was required in 12 studies 
necessitating the use of valve sparing aortic root replacement 
with a reimplantation (9-16,18-20) or remodelling 
(7,13,14,16,18,19) technique. The need for aortic root 
replacement was reported in a median of 93.5% (range, 
1-100%) of patients from the 12 studies. This represented 
52% of all the patients included in the 17 studies. 
The studies reported a median cardiopulmonary bypass 
time of 143 mins (range, 64-175 mins) (7-9,12,13,16,17,20,21) 
and a median cross-clamp time of 125 mins (range, 87-
138 mins) (6-9,11-13,16,17,20,21). The prevalence 
of concomitant cardiac procedures at the time of AV 
repair had a median value of 24.5% (range, 1.9-80.9%) 
(4,6-12,16,18,20,21). The median rate of redo cardiac 
surgery at the time of repair was 5.4% (range, 0-11.8%) 
(6,8,12,13,16,19-21). 
Early outcomes
Early mortality rate was provided in all of the included 
studies (4,6-21) (Table 2). The pooled, fixed effect estimate 
of early mortality was 2.6% (95% CI: 1.4-4.4%, I2=0%). 
Eleven studies reported a median perioperative neurological 
event rate of 1% (range, 0-7%) (4,6-8,10,12,13,15,16,20,21). 
The requirement for exploratory resternotomy for post-
operative bleeding occurred at a median of 3% (range, 
Table 1 Study characteristics
Author (Reference) Year Patients (N) Age (yrs) F/U (yrs) F/U (pt-yrs) Preop. AI (>2+) (%) Marfan (%) Bicuspid AV (%)
Aicher (4) 2010 640 56 4.8 3,072 NR NR 32
Lansac (6) 2010 144 54.4 2.2 317 NR 13 22.9
Lansac (7) 2006 83 49.3 1.4 116 32.9 20.5 4.8
Boodhwani (8) 2009 264 54 3.9 1,030 74.6 NR 34.1
DePaulis (9) 2010 278 56 4.3 1,195 48.9 15.1 11.1
Settapani (10) 2009 60 60 2.4 144 64 5 15
Urbanski (11) 2010 106 61 1.4 148 60 NR NR
Doss (12) 2010 66 41.2 5.1 337 0 NR 100
Badiu (13) 2010 102 47 2 204 93.3 20.6 10.8
Cameron (14) 2009 85 33 15 1,275 NR NR NR
Svensson (15) 2010 129 NR 3 387 28.4 47.3 NR
David (16) 2010 289 48 7.3 2,110 51.2 34 8.3
Izumoto (17) 2006 40 61 3.6 144 NR NR NR
Tanaka (18) 2011 60 33 4.6 276 23.3 90 NR
Oka (19) 2011 101 49.7 5 505 70.3 23.8 11.9
Kallenbach (20) 2005 284 53 3.4 966 50.8 19 6
Minakata (21) 2004 160 55 4.2 672 60.3 NR 33.8
Preop. AI, preoperative aortic valve insufficiency; F/U, follow up; N, number; NR, not reported; yrs, years; pt-yrs, patient-years; AV, aortic valve
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0-10%) in ten studies (4,7-10,12,13,16,20,21). A median 
of 2% (range, 0-16%) of patients required early AV 
reintervention due to failure of primary AV repair (6-
8,16,20,21). 
Late outcomes and valve-related events
Data on late bleeding events was only available from two 
studies, and both of these reported no bleeding complications 
(7,19). Operated valve endocarditis was reported as an 
outcome in 8 studies (6,8,12,14-16,20,21), with a median 
event rate of 0.23%/pt-yr (range, 0-0.78%/pt-yr) (Table 2). 
The composite outcome measure of late neurological events 
and thromboembolism reported a rate of 0.52%/pt-yr (0-
0.95%/pt-yr) (4,6-9,16,17,20,21). Late AV re-intervention 
requiring AV replacement or re-repair occurred at a rate 
of 2.4%/pt-yr (range, 0-4.2%/pt-yr) (4,6-21). The median 
freedom from AV re-intervention estimated from survival 
curves was 92% (range, 87-98%) at 5 years (8-10,13,16-
19,21). The survival curve estimates of freedom from late 
recurrent AI >2+ was a median of 88% (range, 87-100%) 
at 5 years (4,8,12,13,16,19). Late mortality was pooled to 
produce a fixed effects summary estimate of 1.3%/pt-yr 
(95% CI: 0.9-2.1%/pt-yr, I2=0%) (6-10,14-16,18-21).
Discussion
Aortic valve preservation and repair is a promising 
alternative to aortic valve replacement in selected patients 
with aortic valve disease. Data on outcomes following 
aortic valve repair is largely limited to single center case 
series with variable duration of follow-up. In this systematic 
review, we identified a contemporary series of 17 such 
observational studies including over 2,800 patients from 
16 centers. We found that only one study reported all 
outcomes as per guidelines for reporting valve related 
morbidity (2). In-hospital mortality following aortic valve 
repair was acceptable at 2.6%. The incidence of valve 
related complications was also low. Recurrent aortic valve 
insufficiency or stenosis requiring AV re-operation occurred 
at a median rate of 2.4%/pt-yr. 
Systematic review of outcomes following aortic valve 
repair is clearly needed to inform decision making for 
patients with aortic valve disease who may be eligible for 














Aicher (4) 2010 83 NR NR 3.44 0.16 1.2 NR
Lansac (6) 2010 58.4 NR 100 2.8 0.32 2.5 1.6
Lansac (7) 2006 6.2 NR 100 3.6 NR 4.2 0
Boodhwani (8) 2009 † NR NR 1.14 0.10 0 1.1
DePaulis (9) 2010 9 100 NR 1.80 NR 1.4 0.42
Settapani (10) 2009 5 100 NR 1.67 NR 3.5 1.4
Urbanski (11) 2010 9.4 1 NR 0 NR 0 NR
Doss (12) 2010 100 25.8 NR 0 0.30 0 3.0
Badiu (13) 2010 60.8 72.5 27.5 0.98 NR 2.4 0.40
Cameron (14) 2009 NR 53 47 0 NR 0.47 0.16
Svensson (15) 2010 42 100 NR 0 0.78 1.0 0.26
David (16) 2010 38.1 78.9 21.1 1.73 0.14 0.33 1.2
Izumoto (17) 2006 80 NR NR 2.5 NR 3.5 NR
Tanaka (18) 2011 8.4 88.3 11.7 0 NR 0 1.5
Oka (19) 2011 50.5 99 1 0 NR 1.9 2.0
Kallenbach (20) 2005 6.3 100 NR 3.17 0.41 1.5 2.1
Minakata (21) 2004 100 NR NR 0.63 0 2.4 2.4
†, tailored to specific etiology; ‡ composite endpoint: late AVR and re-repair; NR, not reported; pt-yr, patient-year; mort., mortality; 
OVE, operated valve endocarditis
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repair. However, the lack of randomized trials and non-
randomized studies comparing aortic valve repair with 
replacement makes it difficult to define the role of repair 
in the management of aortic valve disease. While there is a 
wealth of data that exists on outcomes following aortic valve 
replacement, data on outcomes following aortic valve repair 
is limited to selected centers and surgeons. Combining data 
from these observational studies, although tempting, comes 
with important challenges. First, the patient population 
and the surgical techniques for aortic valve repair are 
continually evolving. Therefore, outcomes from older 
series may not reflect current practice. Second, the length 
of follow-up among studies is variable and often limited to 
a few years. As such, only a handful of studies may provide 
the much needed long-term data. Third, outcomes are often 
not reported according to standardized definitions from 
guidelines for reporting morbidity and mortality following 
valvular interventions. Fourth, there are occasionally 
multiple publications from the same center that involved 
overlapping cohorts of patients undergoing aortic valve 
repair. Lastly, meta-analytic techniques for failure-time 
data, which comprises the majority of outcomes following 
aortic valve repair, are infrequently used and are not well 
developed. This makes it difficult to quantitatively combine 
data to derive summary measures of outcome. 
Despite these challenges, important messages regarding 
aortic valve repair can be derived from this systematic 
review. Data from over 2,800 patients confirms that 
aortic valve preservation and repair may be performed in 
experienced centers with a low operative mortality. Early 
morbidity and re-intervention rates are also low in the 
published literature despite the complexity of the surgical 
procedures with many patients requiring associated aortic 
root replacement and some presenting with acute aortic 
syndromes. An important reason for the low mortality and 
morbidity likely relates to the relatively young age and 
appropriate selection of patients. The median age of the 
patients included in this review was 54 years and very few 
patients (~5%) were undergoing re-operative surgery. 
The mid- to long-term outcome following aortic valve 
repair appears to be acceptable. Five-year rates of freedom 
from reoperation are above 90%. There is, however, limited 
data on 10-year outcome. Extrapolating from an average 
linearized rate of re-operation of 2.4%/pt-yr, freedom 
from reoperation at 10-years is likely around 75-80%. 
This compares favourably to bio-prosthetic aortic valve 
replacement, which in this population, carries a median 
durability of approximately 8 to 10 years (i.e., 50% of 
bioprosthetic valves fail at approximately 10 years). The 
risk of re-operation is also higher with aortic valve repair 
versus mechanical valve replacement where the freedom 
from reoperation is typically over 90% at 10 years. It is also 
important to note that the rates of reoperation are highly 
variable between centers with linearized rates of less than 1% 
in some centers and close to 4% in others.
In contrast to prosthetic aortic valve replacement, however, 
the risk of thromboembolic complications was low at 0.5%/
pt-yr. The linearized risk of thromboembolic complications 
following mechanical or biologic aortic valve replacement 
is estimated at 1-2%. It is reported to be higher following 
composite replacement of the aortic valve and root with a 
mechanical prosthesis, being as high as 10%/pt-yr in some 
series. This translates to a risk of close to 10-20% over 10 years 
in patients with mechanical valve replacement compared to 
approximately to 5% over 10 years with aortic valve repair. 
Perhaps the most important issue related to outcomes 
following aortic valve repair is the generalizability of the 
findings. Aortic valve repair is still performed at certain 
specialized centers in selected patients and within those centers, 
only by a handful of surgeons. The published outcomes, thus, 
may not be generalized to all patients undergoing aortic valve 
repair. The published studies are also likely to include the 
learning curve of many surgeons and with improvements in 
techniques may overestimate the risk of reoperation.
In summary, this systematic review confirms the low 
operative risk of selected patients undergoing aortic valve 
preservation and repair in specialized centers. The risk of 
aortic valve re-intervention is acceptable and better than 
that expected with a bioprosthetic valve replacement. 
However, patients undergoing repair do carry a risk of 
reoperation in the long-term, which may reduce with 
improving surgical technique and better patient selection. 
The burden of thromboembolic and bleeding complications 
is substantially lower in patients undergoing repair 
compared to mechanical valve replacement. There is a need 
for long-term follow-up studies with meticulous reporting 
of outcomes following AV repair as well as comparative 
studies with aortic valve replacement. 
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